Effectiveness of Vojta Therapy on Gross Motor Function in Children with Cerebral Palsy: A Randomized Controlled Trial
Phase 2
Completed
- Conditions
- Cerebral palsyGross motor function classification system 4 and 5Cerebral palsyGross motor function classification system 4 and 5
- Registration Number
- TCTR20190712002
- Lead Sponsor
- Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Cerebral Palsy with GMFCS Level IV-V Patient
Age 2-12 Years
Consent Signed by Primary Caregiver
Caregiver is Able to Provide Home Program
Exclusion Criteria
Acute Fever(Core BT>39c) at the time of training
Underlying disease eg. Heart Disease, Specific Musculoskeletal Disease,(Ex-Osteogenesis Imperfecta)
Received Vojta Therapy or Conventional Physiotherapy within 3 Months Before the Study
Plan to Adjust Dosage of Anti-Spastic Drug during Study
Botulinum Toxin Injection in Lower Extremities within 6 Months Before the Study
History of Surgery of Lower Extremities within 12 Months Before the Study
History of Seizure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gross motor function Before and after treatment Gross motor function measurement 88(Subdimension A,B and C)
- Secondary Outcome Measures
Name Time Method Gross motor function Before and after treatment Gross motor function measurement 88(Total score),Range of motion of hip knee and ankle Before and after treatment Goniometer,Caregiver's satisfaction After treatment Questionnaire